| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $11,559 | $12,642 | $13,399 | $14,282 | $15,828 |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $1,358 | $1,363 | $1,004 | $1,175 | $1,682 |
| Net Income | $944 | $992 | $676 | $718 | $1,142 |

Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $11,559 | $12,642 | $13,399 | $14,282 | $15,828 |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $1,358 | $1,363 | $1,004 | $1,175 | $1,682 |
| Net Income | $944 | $992 | $676 | $718 | $1,142 |
Over the five-year period from 2020 to 2024, UNIVERSAL HEALTH SERVICES, INC. has demonstrated consistent revenue growth—from approximately USD 11.56 billion in 2020 to around USD 15.83 billion in 2024. This steady increase, roughly 37% over the period, reflects the company’s ability to expand its top line despite fluctuations in other metrics. While gross profit figures were not disclosed, operating income and net income provide additional insights into operational performance. Notably, operating income hovered around USD 1.36 billion in both 2020 and 2021, dipped considerably by about 26% to USD 1.00 billion in 2022, and then rebounded to USD 1.68 billion by 2024. Net income experienced a similar pattern, dropping from nearly USD 992 million in 2021 to around USD 676 million in 2022 before recovering to approximately USD 1.14 billion in 2024. The significant decline in both operating and net income in 2022—exceeding a 20% drop year-over-year—suggests there may have been operational or market challenges during that period. Possible drivers for this swing could include shifts in healthcare reimbursement rates, regulatory pressures, or temporary operational disruptions common within the healthcare industry. However, the strong recovery in 2023 and 2024 indicates that the company effectively addressed these challenges, restoring profitability. Overall, UNIVERSAL HEALTH SERVICES, INC. appears to maintain solid financial health and operational resilience, with robust revenue growth and a capacity to rebound from short-term income fluctuations. This performance, set against the backdrop of the competitive healthcare services market, suggests a sustainable outlook for the company moving forward.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.